...
首页> 外文期刊>Pediatric Nephrology >Expression of fibrosis-associated molecules in IgA nephropathy treated with cyclosporine
【24h】

Expression of fibrosis-associated molecules in IgA nephropathy treated with cyclosporine

机译:环孢素治疗IgA肾病中纤维化相关分子的表达

获取原文
获取原文并翻译 | 示例
           

摘要

Cyclosporine (CsA) treatment in immunoglobulin A nephropathy (IgAN) is controversial and has not been widely studied. The aim of this study was to investigate the effects of CsA on renal histology and the expression of interstitial fibrosis-associated molecules in childhood IgAN. The subjects were 18 children (age 4.2–13.9 years; male:female 13:5) who had been treated with CsA for 8 or 12 months and who had renal biopsies before and after treatment. Renal biopsies were assessed by routine histology and immunohistochemistry against osteopontin (OPN), transforming growth factor-β (TGF-β), CD68, and CD34. The degree of proteinuria and mesangial IgA deposits decreased or disappeared after treatment in all cases, and the percentage of patients with diffuse mesangial proliferation decreased from 44.4 to 22.2%. However, interstitial fibrosis developed or was aggravated in nine patients (50%) after treatment and was associated with an increased degree of interstitial inflammation in five patients. Tubular OPN expression (45.3 ± 23.4 vs. 37.6 ± 19.3%) and the degree of CD68-positive macrophage infiltration (136.1 ± 88.2 vs. 132 ± 86.0/mm2) were not increased after CsA treatment, but TGF-β expression was significantly increased (6.4 ± 4.2 vs. 13.3 ± 9.9%; p = 0.025). Microvascular density was increased and peritubular capillaries were of small caliber in inflamed areas. We conclude that increased levels of TGF-β and the development of interstitial fibrosis limit the long-term use of CsA in IgAN patients. Osteopontin and macrophages may be indirectly involved in renal fibrosis by prolonging interstitial inflammation rather than by directly increasing TGF-β expression.
机译:免疫球蛋白的环孢素(CsA)治疗肾病(IgAN)有争议,尚未得到广泛研究。这项研究的目的是调查CsA对儿童IgAN肾脏组织学和间质纤维化相关分子表达的影响。受试者为18名儿童(年龄4.2-13.9岁;男:女13:5),他们接受了CsA治疗8或12个月,并且在治疗前后进行了肾脏活检。通过常规组织学和免疫组织化学对骨桥蛋白(OPN),转化生长因子-β(TGF-β),CD68和CD34进行肾活检。治疗后蛋白尿和肾小球系膜IgA沉积的程度均降低或消失,弥漫性肾小球膜增生的患者比例从44.4%下降至22.2%。但是,治疗后9例(50%)的间质纤维化发生或加剧,与5例间质炎症的程度增加有关。 CsA处理后,管状OPN表达(45.3±23.4 vs. 37.6±19.3%)和CD68阳性巨噬细胞浸润程度(136.1±88.2 vs. 132±86.0 / mm 2 )没有增加,但TGF-β的表达明显增加(6.4±4.2对13.3±9.9%; p = 0.025)。在发炎区域,微血管密度增加且肾小管毛细血管口径较小。我们得出的结论是,Tgf-β水平升高和间质纤维化的发展限制了IgAN患者长期使用CsA。骨桥蛋白和巨噬细胞可能通过延长间质炎症而不是直接增加TGF-β的表达而间接参与肾脏纤维化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号